Nasal delivery of exenatide
Targeting cells in the olfactory bulb using antidiabetic drug.
AUDIO VERSION AVAILABLE.
Targeting cells in the olfactory bulb using antidiabetic drug.
AUDIO VERSION AVAILABLE.
Researchers are using gene editing to remove alpha-synuclein.
AUDIO VERSION AVAILABLE
First reprogrammed stem cell trial has begun in Japan
PARP ensyme as an important target for disease modification
BIIB054 seen to reduce spread of misfolded a-synuclein
Drugs with the potential of stopping, slowing or reversing Parkinson’s